Literature DB >> 77729

Rhabdomyolysis as a complication of 5-azacytidine.

H P Koeffler, C M Haskell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 77729     DOI： 10.1203/00006450-199501000-00005

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  5 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

2.  Rhabdomyolysis: an unusual complication of cytotoxic chemotherapy.

Authors:  R J Levy; J A Sparano; G Khan
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

3.  Rhabdomyolysis in a Healthy Peripheral Blood Stem Cell Donor following Mobilization with Filgrastim.

Authors:  Sibel Hacioglu; Fevzi Altuntas; Leylagul Kaynar; Ismail Sari; Turkan Patiroglu; Mustafa Cetin
Journal:  Transfus Med Hemother       Date:  2009-03-23       Impact factor: 3.747

4.  Embryotoxicity of 5-azacytidine in mice. Phase- and dose-specificity studies.

Authors:  W Schmahl; P Török; H Kriegel
Journal:  Arch Toxicol       Date:  1984-07       Impact factor: 5.153

5.  Severe acute rhabdomyolysis induced by multi-agent chemotherapy for alveolar rhabdomyosarcoma in a 15-year-old female: a case report.

Authors:  Hiroshi Matsuzaki; Yuhki Koga; Aiko Suminoe; Utako Oba; Tomohito Takimoto; Toshiro Hara
Journal:  Case Rep Oncol       Date:  2013-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.